Table 4. Levels of in situ B23/NPM in tumour biopsies.
| Tumour samples | Group I (35 mg), N=6 | Group II (70 mg), N=6 |
|---|---|---|
| Baseline | 56.0±17.6 | 52.8±15.1 |
| Post CIGB-300 | 36.4±18.9 | 46.0±14.7 |
| Student's t-test (p) | 0.14 | 0.03 |
Data are reported as mean±s.d.
| Tumour samples | Group I (35 mg), N=6 | Group II (70 mg), N=6 |
|---|---|---|
| Baseline | 56.0±17.6 | 52.8±15.1 |
| Post CIGB-300 | 36.4±18.9 | 46.0±14.7 |
| Student's t-test (p) | 0.14 | 0.03 |
Data are reported as mean±s.d.